Continue to Site

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes

By

Abbott Xience Skypoint stent
Abbott’s Xience Skypoint stent. [Image from Abbott]
Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally.

Xience Skypoint has received FDA approval, CE mark and PMDA approval in Japan for the broadest expansion with the availability of extended sizes of 4.5 mm and 5 mm offerings.

Get the full story at our sister site, Drug Delivery Business News.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.